UPDATED Aug 12, 2024
Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TYRA | US$20.22 | 2.0% | 30.5% | US$1.1b | US$25.00 | PB2.8x | E10.2% | n/a | ||
SPRY | US$10.85 | 16.4% | 56.8% | US$1.1b | US$19.00 | PS2103.6x | E52.2% | n/a | ||
SAVA | US$22.03 | -37.2% | 20.4% | US$1.0b | n/a | PB5.6x | E-35.0% | n/a | ||
TARS | US$26.21 | 21.7% | 55.7% | US$1.0b | US$59.22 | PS12x | E64.3% | n/a | ||
ELVN | US$21.32 | -3.6% | 29.6% | US$1.0b | US$34.00 | PB3.2x | E-21.8% | n/a | ||
XNCR | US$15.80 | -11.1% | -32.2% | US$991.8m | US$32.36 | PS7.3x | E22.3% | n/a | ||
GRCL | US$10.25 | -0.2% | 388.1% | US$990.8m | US$10.58 | PB4.4x | E-5.5% | n/a | ||
AUTL | US$3.68 | -13.4% | 32.4% | US$976.4m | US$10.56 | PS93.3x | E52.7% | n/a | ||
CGEM | US$16.30 | -7.1% | 58.7% | US$972.3m | US$32.50 | PB1.4x | E-13.0% | n/a | ||
VRDN | US$15.29 | 3.5% | -22.8% | US$959.6m | US$35.19 | PS3391.9x | E38.2% | n/a | ||
HUMA | US$6.62 | -15.9% | 63.7% | US$942.0m | US$11.00 | PB30.1x | E49.0% | n/a | ||
AMYT | US$14.70 | 0.7% | 86.5% | US$940.7m | US$20.75 | PS3.9x | E53.9% | n/a | ||
MDXG | US$6.26 | 0.2% | -16.2% | US$939.6m | US$12.20 | PE11.7x | E-7.0% | n/a | ||
COGT | US$8.50 | -7.0% | -29.9% | US$939.1m | US$16.36 | PB3.6x | E33.5% | n/a | ||
TNGX | US$8.50 | -3.7% | 21.6% | US$910.7m | US$15.63 | PS21.4x | E-3.3% | n/a | ||
ANAB | US$33.75 | 4.3% | 75.1% | US$907.2m | US$53.36 | PS30.4x | E-17.2% | n/a | ||
RLAY | US$6.51 | -8.3% | -41.6% | US$897.1m | US$21.90 | PS24.8x | E-9.2% | n/a | ||
LQDA | US$12.21 | 10.9% | 73.9% | US$894.6m | US$27.00 | PS63.2x | E65.2% | n/a | ||
GYRE | US$10.67 | 5.3% | n/a | US$889.3m | n/a | PS7.9x | n/a | n/a | ||
PRAX | US$51.82 | -6.1% | 208.5% | US$886.5m | US$139.67 | PS403.9x | E29.0% | n/a | ||
PHVS | US$15.73 | -8.7% | -14.6% | US$865.4m | US$33.52 | PB2.2x | E16.0% | n/a | ||
ETNB | US$7.82 | -6.8% | -52.0% | US$826.1m | US$31.33 | PB1.6x | E17.3% | n/a | ||
EOLS | US$13.05 | -2.0% | 33.4% | US$817.7m | US$22.43 | PS3.5x | E69.1% | n/a | ||
CATX | US$12.09 | 0.9% | 157.2% | US$810.5m | US$22.36 | PS534.2x | E11.3% | n/a |